The relationship between the volume of distribution, assessed according to the two-compartmental pharmacokinetic model, and extracellular water estimated by bioimpedance was studied in mechanically ventilated patients with sepsis and capillary leak. A prospective observational study was performed in a twenty-bed general intensive care unit in the university hospital.
Sepsis and multiple organ dysfunction induce an increase in the water content of the body mainly in the extracellular space. Antibiotics are primarily distributed in extracellular water, therefore antimicrobial prescribing in sepsis must take into account the increase in volume of distribution and variable drug clearance [1] [2] [3] . At different stages of the disease process, antibiotic requirements in septic intensive care unit patients may be similar, less or greater than in patients on the conventional ward 4 . Subtherapeutic antibiotic concentrations in those patients may account for treatment failures and may contribute towards emergence of bacterial resistance [5] [6] [7] .
Measurement of serum levels of antibiotics is recommended for drugs with a low therapeutic index and is routinely practised in the ICU for antibiotics like aminoglycosides and glycopeptides. One of the analytic methods used in therapeutic drug monitoring is fluorescent polarization imunoassay. By adopting a two-compartmental pharmacokinetic model, volumes of distribution (Vd) of an antibiotic can be calculated. Oscillations of serum levels and kinetic parameters can be used to predict the course of serum levels after each dose, thus allowing for an appropriate dose to be administered at the correct time 8 .
Bioimpedance is a noninvasive measure of total body water (TBW) and its component in intracellular (ICW) and extracellular (ECW) space. Impedance values obtained from healthy volunteers correlate well with body composition values derived from a variety of other measures like anthropometry, densitometry and tritium dilution technique 9, 10 . However, there are less convincing data about the use of bioimpedance methodology in critically ill [11] [12] [13] . By monitoring changes in bioimpedance sensed by superficial electrodes attached to the limbs, a rough measure of total body water and extracellular volume can be obtained. Segmental bioimpedance measurements appear to predict with reasonable accuracy the extracellular and intracellular water volume status among patients with abdominal surgery or those with ascites and pleural effusion 14 . Bioimpedance has still not found universal acceptance in spite of the introduction of limited frequency and multifrequency bioimpedance techniques. A strong relationship of impedance values with ECW has been reported at low frequencies (1-50 kHZ) and while at high frequencies (50-100 kHz), bioimpedance correlates well with TBW 9,10,12,15 . Since changes in impedance are not always well correlated with a change in the size of fluid compartments in pathological conditions, we were keen to study the clinical utility of bedside measurement in a group of patients known to be associated with fluid overload.
We hypothesize that in critically ill patients with sepsis, the volume of distribution of an antibiotic (vancomycin or netilmicin) would correlate well with bioimpedance measurement of ECW. If proven to be true, we conjectured that a model could be developed which would allow more accurate drug dosing based on the information obtained by bioimpedance assessment.
MATERIALS AND METHODS
The prospective observational study was performed in a twenty-bed general ICU in the University Hospital and was approved by the Hospital Ethics Board. Therapeutic drug monitoring is part of the routine management of patients in our ICU. In view of this and the noninvasive character of bioimpedance measurement, the Ethics Board waived the need for written informed consent.
Twenty-eight patients fulfilling two or more criteria for Systemic Inflammatory Response Syndrome (SIRS) 16, 17 were included in the study. Capillary leak in the presence of sepsis was defined as the occurrence of a positive fluid balance, signs of generalized oedema, conjunctival chemosis and a decrease in serum total protein 18, 19 . Patients with obvious ascites, pleural effusions or those on renal replacement therapy were excluded from the study. Patients with overt haemodynamic instability were also excluded.
Sixteen patients were administered vancomycin and twelve patients netilmicin over more than 48 hours. Initial daily dose of vancomycin was 20 to 30 mg/kg and that of netilmicin was 5 to 6 mg/kg among patients with normal or mildly reduced renal function (over 60 ml/min/1.73 m 2 ) 4,6,20,21 . Creatinine clearance (Ccr) was calculated from a sample of urine collected for 24 hours at the urine prior to the commencement of the study.
Samples were drawn from an indwelling arterial line for analysis of antibiotic concentrations just before the drug was administered and at one hour and four hours after the end of an antibiotic infusion over 30 minutes. Serum concentrations were measured by fluorescence polarization imunoassay (FPIA) using an ABBOTT TDx analyser. All measurements were repeated after an interval of 24 hours.
Concentration/time drug oscillations were simulated using the MW\Pharm v.3.30 software (Medi Ware/Medisoft, Groningen) using a two compartment model with a Bayesian fit procedure. All data including the weight, height and renal function as assessed by creatinine clearance values were entered into the software program to derive a number of parameters 8 . These included volume of distribution of the central compartment (V 1 ), volume of distribution (Vd area ) and total body clearance of the antibiotic (Cl). A prediction of the course of serum drug levels was made. Information derived from this pharmacokinetic analysis were compared with the initial dosing scheme and changes were recommended for each patient.
Immediately after drawing a blood sample at four hours after drug infusion for pharmacokinetics, bioimpedance measurements were taken. Bioimpedance was analysed at multiple frequencies (1, 5, 50 and 100 kHz) using the B.I.A.2000-M device (Data Input GmbH, Frankfurt, Germany). Electrodes were placed on the dorsal surface of the hand and foot at the metacarpals and metatarsals. Patients were placed supine while on mechanical ventilation, haemodynamically stable with maintenance infusions. Resistance (R), reactance (Xc) and phase angle (alpha) were measured and all bioimpedance measurements were repeated after 24 hours. The data were entered along with weight and height into a computer program Nutri 4 (Data Input GmbH, Frankfurt, Germany) for the calculation of ECW volume and TBW volume. TBW was calculated from measured resistance according to the formula of Kushner and coworkers 22 . ECW was calculated according to the modified formula of Segal and colleagues 23 . Extracellular water calculated as a percentage of total body water (ECW/TBW) is considered an index of volume load 24, 25 . To assess the influence of alterations in body composition between two measurements taken 24 hours apart, the changes in TBW and ECW were recorded and compared to the expected physiological norm 26 and to the total fluid balance (difference between the fluid intake and output over 24 hours).
Statistical analysis was performed using Statistica Software, version 6.0. The test of normality of data distribution was carried out using Normal Propability Plot and Shapiro-Wilk W Test. Parameters of body water distribution (ECW, TBW and ECW/TBW index) obtained by bioimpedance were correlated with distribution volume parameters (V 1 , Vd area ) derived from pharmacokinetic modeling. Regression analysis was applied for prediction of pharmacokinetic parameters using bioimpedance parameters.
RESULTS
Patient characteristics are shown in Table 1 . The mean age of patients was 58.8±18 years and the mean APACHE II score was 21.5±7.3. ICU mortality was 32.1% (9 of 28 patients). Seventeen patients (60.7%) received catecholamine support. Sixteen patients of those 17 were treated with noradrenaline (mean 0.06±0.08 µg/kg min, median 0.03, quartile range 0.06), in three patients in combination with dobutamine (range 1.0-3.5 µg/kg min). One patient received dobutamine (2.5 µg/kg min) only.
The balance of fluids during the interval of 24 hours between the two measurements showed a mean change of 0.16±1.47 l/24 h (median 0.10 l/24 h and quartile range 1.87 l/24 h). The mean change of ECW was 0.31±1.81 l/24 h (median 0.10 and quartile range 1.85 l/24 h) and TBW change was 0.60±3.65 l/24 h (median -0.45 and quartile range 2.15 l/24 h) during the same period. A significant correlation between the ECW change and the balance of fluids was found (r=0.82, P<0.0001) as well as between the TBW change and the balance of fluids (r=0.74, P<0.0001).
Thirty-two measurements were taken in 16 patiens receiving vancomycin. The results are shown in Table  2 . The initial dosage of vancomycin corrected according to the GFR was compared with the recommended dosing after the pharmacokinetic analysis. Only three patients received the correct dosage (18.8%). In 13 other patients (81.2%) serum drug concentrations above the recommended therapeutic range were reached, one suffering severe renal insufficiency (16.8 ml/min/1.73m 2 ). The dose was reduced in two patients, the dosing interval was prolonged in other 10 patients and both dose and interval were changed in one of those 13 patients.
Twenty-four measurements were performed in 12 patients treated with netilmicin. The results are shown in Table 3 . The initial dosage of netilmicin had to be corrected in eight patients (66.7%). Only four patients (33.3%) of the study group received the correct dosage. In six (50.0%) patients the dosage had to be reduced, three of them suffered from severe renal insufficiency (GFR 18.5-32.5 ml/min/1.73m 2 ). The dose was reduced in three patients, the dosing interval was prolonged in two patients and both were changed in another patient of those six. The dosage was increased in two patients of those 12 studied and glomerular hyperfiltration was recorded in those two patients (GFR range 132.3-134.0 ml/min/1.73m 2 ).
DISCUSSION
This study confirms that sepsis is associated with an increase in ECW but with little increase of TBW as assessed by bioimpedance 11 . Almost 50% of TBW accumulates in the extracellular space as a result of an alteration in capillary permeability. An increase in the ratio of ECW to TBW is a frequent observation, not only due to an expansion of ECW but also as a result of catabolism and loss of body protein accompanied by a loss in intracellular water 11, 12 . On the other hand the increase in TBW may parallel the increase in ECW in the early stage of sepsis in particular 27, 28 .
Changes of ECW and TBW correlated well with the fluid balance over 24 hours between the two bioimpedance measurements in all patients. Bioimpedance is thus a reliable measure of change in body fluid compartments.
The mean volume of distribution of studied antibiotics was also increased above normal for both, but for netilmicin in particular 1,20 suggesting a relationship with capillary leak. Statistical analysis showed a significant correlation between pharmacokinetic parameters of volume and volumes measured by bioimpedance among vancomycin treated patients. A similar but less significant result was found among patients treated with netilmicin. In other words, estimates of volume change by bioimpedance paralleled changes in the volume of distribution calculated by pharmacokinetic modelling. The lack of better agreement could, in part, be explained by the fact that pharmacokinetic estimation of volume (Vd) is actually a mathematical construct that is influenced as much by protein binding as by actual increases in volume of distribution. Bioimpedance analysis only estimates the actual body water. In critically ill patients, several factors affect the volume of distribution of antibiotics that in turn influence antibiotic levels in serum and tissues.
The correlation found between ECW/TBW and V 1 of netilmicin was not found for vancomycin. The findings could be explained by the better penetration of vancomycin into the tissues than netilmicin and by different protein binding of both drugs. The total clearance of the drugs (Cl) correlated with GFR represented with clearance of creatinine which confirms the importance of renal function assessment for the adequate dosage of both drugs.
The Bayesian program was used in pharmacokinetic modelling as it is probably significantly more precise and less biased than the Moellering or Matzke method and less biased than the Sawchuk-Zaske method in predicting both peak and trough concentrations 29, 30 . Dosing based on individual pharmacokinetic data is a more reliable way of achieving therapeutic blood concentrations than a nomogrambased dosing system 31 . In this study we wanted to develop a system by which it would be possible for us to individualize dosing of renotoxic antibiotics for ICU patients. We expected to find low therapeutic levels of both antibiotics in line with an expected increase in extracellular water and distribution volumes in septic ICU patients. Suprisingly, only three patients (18.8%) in the vancomycin group and four patients in the netilmicin group (33.3%) had their dosing regimen correct. In the majority of patients, serum concentration of antibiotics were above the therapeutic level and required a reduction in the dose or extension of the dosing interval. Three patients with a significant impairment of renal function (GFR<40 ml/min/1.73m 2 ) in the netilmicin group and one in the vancomycin group were among those who required a reduction of the dose but this step might have been justified later with regard to their renal function parameters. The hypothesis that it would be possible to adjust the dose of the nephrotoxic antibiotics in terms of increasing the dose according to the bioimpedance estimate of the distribution volume of the agent was not confirmed. In fact, a dosing regimen based on a pharmacokinetic construct of volume (Vd) was also not confirmed. In contrast, drug levels were found to be high in spite of an increase in volume of distribution calculated from pharmacokinetic modelling. A lowered clearance of antibiotics or a higher protein binding are the only two plausible explanations for this finding. Clearance of renally excreted antibiotics is related to the GFR, which at certain times during the septic process can be overestimated by clearance of creatinine 32 , leading to a higher dose administration. The prospect that some of the commonly used antibiotics in the intensive care unit may be bound to acute phase proteins also emerges as a possibility for consideration 33 .
Another explanation for the finding of high serum levels in spite of a demonstrable increase in body water is the possibility of a preferential distribution of antibiotics in the central compartment even in the presence of a capillary leak. Aminoglycosides are seemingly poorly distributed in the extravascular space 34 giving credence to the last of the explanations mentioned above. Data on sub-therapeutic tissue levels of antibiotics (measured by microdialysis) in sick and septic patients also support this contention 35, 36 . Decisions related to the use of antibiotics in the ICU are complex and are based on the pharmacokinetic parameters, microbial sensitivity, site of the infection and presence of the postantibiotic effect 4, 37 . For the moment, routine drug levels will continue to guide therapy in septic ICU patients. Few units around the world will use computerized algorithms for antibiotic dosing in individual patients. Papers suggesting an increase in doses of aminoglycosides 38, 39 during the first few days of sepsis need to be viewed with caution, especially if the suggestion is made on the basis of increases in volume of distribution. Sepsis is a dynamic process and results in multiple conflicting changes in the composition of the body as well as its ability to handle and metabolize drugs. All these need to be factored in while determining the dose and dosing interval of an antibiotic. Bioimpedance that measures only the body water and estimates the extracellular water is unlikely to help in determining the dose requirement of an individual patient.
Our study had an attractive hypothesis but suffered from a few weaknesses. Measurements were done after at least 48 hours of therapy when the patients were haemodynamically stable. Changes in volume that may impact on the decision to give higher doses of antibiotics are frequently seen in the early unstable phase of sepsis. Also the timing of the study matters for another important reason. Drug levels measured after a few days of therapy reflect steady state kinetics that are more profoundly influenced by clearances rather than volume of distribution. If we were to consider a future in which we would consider the initial or loading dose of an antibiotic based upon volume of distribution to achieve a good therapeutic level, bioimpedance analysis may still have something to offer.
